Diversified Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Sell |
3,939
-105
| -3% | -$7.25K | 0.01% | 781 |
|
|
2025
Q1 | $281K | Buy |
4,044
+798
| +25% | +$55.4K | 0.01% | 756 |
|
|
2024
Q4 | $279K | Buy |
3,246
+395
| +14% | +$34K | 0.01% | 761 |
|
|
2024
Q3 | $339K | Buy |
2,851
+53
| +2% | +$6.31K | 0.01% | 701 |
|
|
2024
Q2 | $399K | Sell |
2,798
-1,399
| -33% | -$200K | 0.01% | 602 |
|
|
2024
Q1 | $539K | Buy |
4,197
+30
| +0.7% | +$3.85K | 0.02% | 492 |
|
|
2023
Q4 | $431K | Sell |
4,167
-3,396
| -45% | -$351K | 0.01% | 543 |
|
|
2023
Q3 | $688K | Buy |
7,563
+393
| +5% | +$35.7K | 0.03% | 352 |
|
|
2023
Q2 | $580K | Buy |
7,170
+1,466
| +26% | +$119K | 0.02% | 418 |
|
|
2023
Q1 | $454K | Buy |
5,704
+168
| +3% | +$13.4K | 0.02% | 498 |
|
|
2022
Q4 | $375K | Buy |
+5,536
| New | +$375K | 0.02% | 501 |
|